Schrodinger, Inc. - Common Stock (NQ:SDGR)

30.31 -0.15 (-0.49%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Largest Clinical-Stage BioTech Drug Stocks Declined 6% ↗

June 22, 2024

Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they...

Via Talk Markets

AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th ↗

June 17, 2024

The global

Via Talk Markets

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

June 14, 2024

From Schrödinger

Via Business Wire

AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week ↗

June 10, 2024

The global

Via Talk Markets

Critical Insights From Schrodinger Analyst Ratings: What You Need To Know ↗

March 01, 2024

Via Benzinga

The 7 AI Categories Were Down 4%, On Average, This Week; Up 1% In May ↗

June 01, 2024

The 7 AI categories we track dropped, down 4.3% this week, and are now only up 1.3% for the month of May.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger to Present at Jefferies Global Healthcare Conference

May 22, 2024

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 17, 2024

From Schrödinger

Via Business Wire

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs ↗

May 16, 2024

AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.

Via InvestorPlace

Topics Artificial Intelligence

What's the Difference Between Biotech Stocks and TechBio Stocks? ↗

May 15, 2024

A few enterprising businesses are marketing themselves differently.

Via The Motley Fool

Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week ↗

May 13, 2024

Via Talk Markets

The 7 AI Categories Declined, On Average, The First Week Of May ↗

May 05, 2024

Via Talk Markets

Topics Artificial Intelligence

Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May ↗

May 05, 2024

We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD.

Via Talk Markets

Etsy Reports Downbeat Earnings, Joins Fastly, DoorDash And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

May 02, 2024

Via Benzinga

SDGR Stock Earnings: Schrodinger Misses EPS, Misses Revenue for Q1 2024 ↗

May 01, 2024

SDGR stock results show that Schrodinger missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 01, 2024

Via Benzinga

Schrödinger Reports First Quarter 2024 Financial Results

May 01, 2024

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 18, 2024

From Schrödinger

Via Business Wire

The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD ↗

April 15, 2024

The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

April 10, 2024

From Schrödinger

Via Business Wire

5 Healthcare Stocks to Buy for 2024 ↗

April 02, 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

Via InvestorPlace

Topics Artificial Intelligence

Invest Like Bill Gates With These 3 AI Stocks to Buy ↗

March 27, 2024

Bill Gates is undoubtedly interested in AI stocks to buy. Here are three of his foundation’s current holdings.

Via InvestorPlace

Topics Artificial Intelligence

Shhh! 7 Small-Cap Stocks That Can Double by 2025 ↗

March 20, 2024

Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year.

Via InvestorPlace

Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

March 20, 2024

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

March 19, 2024

From Schrödinger

Via Business Wire

Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys? ↗

March 18, 2024

AI is a key growth driver for both of these stocks owned by the Gates Foundation Trust.

Via The Motley Fool

Topics Artificial Intelligence

10 Health Care Stocks Whale Activity In Today's Session ↗

March 04, 2024

Via Benzinga

AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD ↗

March 04, 2024

Grand View Research says the global

Via Talk Markets

The Hot List: 3 AI Stocks Worth Buying on Weakness ↗

March 01, 2024

Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness.

Via InvestorPlace

Topics Artificial Intelligence

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 29, 2024

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.